Pharmaceutical manufacturing leaders must manage smaller batches, shorter campaigns, greater complexity, more volatile demand, and ever-increasing quality expectations and approach all this with a level of innovation that matches the rapidly changing pharmaceutical landscape.

From raw material inspection through to QC, root cause analysis and in-process measurement, Malvern has a wealth of experience working in cGxP environments. We understand the need for easy to use analytical tools that provide for robust method development and transfer, with the support of 21 CFR Part 11 compliance and full life cycle documentation.